For CAI there are synergies... the Felix discovery and Blue Spec (for which CAI was proposing about $30M Capex to proceed)... For NVO it is an isolated mill with limited upside.
Perhaps the same negative circumstances of Covid, difficulties in maintaining staffing levels and the rise in inflation impacted NVO in similar ways it hurt CAI? The difference is CAI has been aggressive in acquiring good ground and Nullagine stitches it all together.
CAI Price at posting:
20.5¢ Sentiment: Buy Disclosure: Held
(20min delay)